(1 - 10 von 10
)
Clearbridge BioMedics und Leica Biosystems vermarkten gemeinsam...
www.ots.at
beitragen", so Dr. Michael Paumen, CEO von Clearbridge BioMedics. "Bei LBS
streben wir danach, unseren Kunden auf unserer Bond RX-Plattform die
umfassendsten klinisch relevanten, aufkommenden Technologien ...
Clearbridge BioMedics joins CANCER-ID consortium
www.manufacturingchemist.com
— Dr Michael Paumen, CEO of Clearbridge BioMedics, said: “We believe that the use of liquid biopsy will play a critical role in advancing ... › ...
Clearbridge BioMedics' ClearCellFX1 system achieves U.S. FDA listing...
www.i-micronews.com
I-micronews provides market research and technology reports from any sector. Visit our web site to get news and reports online.
sortiert nach Relevanz / Datum